The FDA questioned whether PureGen is within the classification of human cell, tissue and cellular or tissue-based products that the FDA regulates. Alphatec Spine and Parcell Laboratories plan on working with the FDA to address its questions about PureGen and will share the clinical outcomes gathered to date.
PureGen Osteoprogenitor Cell Allograft has been successfully implanted in more than 500 patients, primarily during lumbar and cervical spine fusions, and no adverse events have been reported.
Read the release about PureGen.
Related Articles to Alphatec Spine:
Alphatec Spine Reports $49.7M in Q1 Revenue, 40.9% Increase
Alphatec Spine Signs Agreement With Merlot OrthopediX for Spine Surgery Technology
Alphatec Spine Receives 510(k) Clearance for Solus System
Alphatec Spine to Answer FDA's Questions on PureGen Product for Spinal FusionsWritten by Laura Dyrda | Wednesday, 27 July 2011 17:15
Alphatec Holdings has commented on a Food and Drug Administration letter sent to Parcell Laboratories regarding Alphatec Spine's PureGen Osteoprogenitor Cell Allograft, according to a company news release.
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies here.
Top 40 Articles from the Past 6 Months
- 22 spine surgeon leadership awards | 2016
- Has Xenco Medical Ushered in the Future of Spine Surgery?
- Zimmer Biomet, Stryker, J&J & more: 26 key notes — AAOS edition
- Dr. James Andrews #5 among richest doctors in the world: 6 points
- Beyond the device: How DePuy Synthes is innovating in orthopedic & spine technology
- Orthopedic surgeons generate $2.7M for affiliated hospitals; 5.5 times what they make — 5 survey findings
- CJR bundles to pay $25k per episode: 8 statistics on cost breakdown
- Dr. Kevin Pauza unsurprised with Tiger Woods' slow back surgery recovery: 5 insights
- Top 10 highest-earning physician specialties — Orthopedics leads for 6th consecutive year
- Novel technologies make a splash in outpatient spine setting — Dr. Nick Shamie weighs in
- PODs under attack again: 5 key notes from the Senate Finance Committee's report
- Where global spine market leaders are headed: 7 key notes on Medtronic, DePuy Synthes, Stryker & more
- 6 statistics on orthopedic surgeon compensation — Which practice setting pays most?
- 21 smart spine surgeons with gifted business minds
- CMS's lowest vs. highest-paid physicians: 5 key points
- Consumer Reports: 34 top-rated US hospitals for hip replacements
- Top 12 most-liked spine surgeons on the internet
- Dr. George Rappard performs 1st US MIS procedure with Sony heads-up display: 5 observations
- Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems
- 5 trends in complex spine surgery
- Which 4 emerging trends will drive the global spine surgery market?
- Orthopedic surgeons leave Salina Regional over on-call payment dispute: 5 things to know
- Andrews Institute adds regenerative medicine, stem cell center: 5 things to know
- Annual & hourly orthopedic surgeon salary — 10 latest statistics
- ISSCR updates stem cell research guidelines; warns against stem cell medical tourism — 5 insights
- The low hanging fruit of HIPAA compliance: 8 best practices
- Zimmer Biomet to acquire LDR in $1B transaction — 9 things to know
- The great PA debate: Should spine surgeons hire them?
- Surgeon entrepreneur: Dr. Kern Singh's quest to make lateral spine surgery more accessible
- Trusting a robot — Dr. Juan Torres-Reveron on performing 1st US ROSA Spine surgery
- MIS spine's promising future — Key insights from SMISS President Dr. Greg Anderson
- 87% of solo practitioners to face MIPS penalty in 2019 — 6 statistics on how Medicare's new payment model may impact solo physicians & small practices
- How Responsive Orthopedics defied the industry norm to make knee, hip devices more affordable — 6 key insights
- Paradigm Spine pays $585k in False Claims Act settlement; denies allegations: 5 things to know
- 12 statistics on social media's presence in the healthcare space
- 5 key notes on the Zimmer Biomet-LDR acquisition & its impact on Texas
- UPMC to pay $2.5M+ to settle neurosurgery-related False Claims Act violation allegations: 7 things to know
- Bundled payments to account for 30%-45% of spine reimbursement in 3 years: 4 insights
- More than half of hospital orthopedic programs unprepared for CMS joint replacement program: 7 takeaways
- 5 key points on Midwest Orthopaedics at Rush's bundled payments making healthcare affordable & transparent